108 related articles for article (PubMed ID: 3021541)
1. Matrix degrading proteinases from human granulocytes: type I, II, III collagenase, gelatinase and type IV, V-collagenase. A survey of recent findings and inhibition by gamma-anticollagenase.
Tschesche H; Fedrowitz J; Kohnert U; Michaelis J; Macartney HW
Folia Histochem Cytobiol; 1986; 24(2):125-31. PubMed ID: 3021541
[TBL] [Abstract][Full Text] [Related]
2. The latent collagenase and gelatinase of human polymorphonuclear neutrophil leucocytes.
Murphy G; Bretz U; Baggiolini M; Reynolds JJ
Biochem J; 1980 Nov; 192(2):517-25. PubMed ID: 6263256
[TBL] [Abstract][Full Text] [Related]
3. Partial purification of collagenase and gelatinase from human polymorphonuclear leucocytes. Analysis of their actions on soluble and insoluble collagens.
Murphy G; Reynolds JJ; Bretz U; Baggiolini M
Biochem J; 1982 Apr; 203(1):209-21. PubMed ID: 6285893
[TBL] [Abstract][Full Text] [Related]
4. Latent collagenase and gelatinase from human neutrophils and their activation.
Tschesche H; Knäuper V; Krämer S; Michaelis J; Oberhoff R; Reinke H
Matrix Suppl; 1992; 1():245-55. PubMed ID: 1480034
[TBL] [Abstract][Full Text] [Related]
5. Comparison of vertebrate collagenase and gelatinase using a new fluorogenic substrate peptide.
Stack MS; Gray RD
J Biol Chem; 1989 Mar; 264(8):4277-81. PubMed ID: 2538433
[TBL] [Abstract][Full Text] [Related]
6. Collagenase activation of latent matrix-degrading proteinases from human plasma fibronectin.
Imhoff JM; Blondeau X; Planchenault T; Emod I; Keil-Dlouha V
Biol Chem Hoppe Seyler; 1990 Feb; 371(2):137-44. PubMed ID: 2159310
[TBL] [Abstract][Full Text] [Related]
7. Different effects of hypochlorous acid on human neutrophil metalloproteinases: activation of collagenase and inactivation of collagenase and gelatinase.
Michaelis J; Vissers MC; Winterbourn CC
Arch Biochem Biophys; 1992 Feb; 292(2):555-62. PubMed ID: 1309976
[TBL] [Abstract][Full Text] [Related]
8. Parathyroid hormone regulation of matrix degrading enzymes in rat osteoblastic osteosarcoma 17/2.8 cells.
Vernillo AT; Ramamurthy NS; Lee HM; Rifkin BR
Res Commun Chem Pathol Pharmacol; 1992 Mar; 75(3):323-39. PubMed ID: 1324516
[TBL] [Abstract][Full Text] [Related]
9. Partial purification and characterization of latent human leukocyte collagenase.
Sorsa T; Suomalainen K; Turto H; Lindy S
Med Biol; 1985; 63(2):66-72. PubMed ID: 2999523
[TBL] [Abstract][Full Text] [Related]
10. Characterization of gelatinase from pig polymorphonuclear leucocytes. A metalloproteinase resembling tumour type IV collagenase.
Murphy G; Ward R; Hembry RM; Reynolds JJ; Kühn K; Tryggvason K
Biochem J; 1989 Mar; 258(2):463-72. PubMed ID: 2539808
[TBL] [Abstract][Full Text] [Related]
11. Human polymorphonuclear leukocyte collagenase and gelatinase. Comparison of certain enzymatic properties.
Williams HR; Lin TY
Int J Biochem; 1984; 16(12):1321-9. PubMed ID: 6099287
[TBL] [Abstract][Full Text] [Related]
12. Eriochrome black T inhibition of human skin collagenase, but not gelatinase, using both protein and synthetic substrates.
Seltzer JL; Eschbach ML; Winberg JO; Bauer EA; Eisen AZ; Weingarten H
Coll Relat Res; 1987 Dec; 7(6):399-407. PubMed ID: 2833373
[TBL] [Abstract][Full Text] [Related]
13. Ovostatin: a novel proteinase inhibitor from chicken egg white. II. Mechanism of inhibition studied with collagenase and thermolysin.
Nagase H; Harris ED
J Biol Chem; 1983 Jun; 258(12):7490-8. PubMed ID: 6305943
[TBL] [Abstract][Full Text] [Related]
14. Tissue kallikrein effectively activates latent matrix degrading metalloenzymes.
Tschesche H; Michaelis J; Kohnert U; Fedrowitz J; Oberhoff R
Adv Exp Med Biol; 1989; 247A():545-8. PubMed ID: 2557753
[No Abstract] [Full Text] [Related]
15. Characterization of a gelatinase from human rheumatoid synovial fluid cells.
Kolkenbrock H; Ali HM; Hecker-Kia A; Buchlow G; Sörensen H; Hauer RW; Ulbrich N
Eur J Clin Chem Clin Biochem; 1991 Aug; 29(8):499-505. PubMed ID: 1659460
[TBL] [Abstract][Full Text] [Related]
16. Collagenase from the culture medium of rabbit colon wall with special reference to the latent type and substrate specificity.
Oyamada I; Kitaoka M; Araki C; Yoshioka H; Usuku G
Gastroenterology; 1983 Aug; 85(2):376-84. PubMed ID: 6305759
[TBL] [Abstract][Full Text] [Related]
17. Purification and characterization of a bone metalloproteinase that degrades gelatin and types IV and V collagen.
Murphy G; McAlpine CG; Poll CT; Reynolds JJ
Biochim Biophys Acta; 1985 Sep; 831(1):49-58. PubMed ID: 2994741
[TBL] [Abstract][Full Text] [Related]
18. Cleavage specificity of type IV collagenase (gelatinase) from human skin. Use of synthetic peptides as model substrates.
Seltzer JL; Weingarten H; Akers KT; Eschbach ML; Grant GA; Eisen AZ
J Biol Chem; 1989 Nov; 264(33):19583-6. PubMed ID: 2555325
[TBL] [Abstract][Full Text] [Related]
19. Neutral proteases of human granulocytes. IV. Interaction between human granulocyte collagenase and plasma protease inhibitors.
Ohlsson K; Olsson I
J Lab Clin Med; 1977 Feb; 89(2):269-77. PubMed ID: 64576
[TBL] [Abstract][Full Text] [Related]
20. Isolation and properties of a metal-dependent endopeptidase from human uterus hydrolysing synthetic collagenase substrates.
Kolkenbrock H; Wieder T; Ulbrich N
Biol Chem Hoppe Seyler; 1991 Feb; 372(2):83-9. PubMed ID: 1650234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
